197896-26-7

Basic information

• Product Name: Cyclohexanol, 2,3,4-tris(phenylmethoxy)-, (1R,2S,3S,4R)-
• CAS NO: 197896-26-7
• Molecular Formula: C27H30O4
• Molecular Weight: 418.533
• Mol File: 197896-26-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Cyclohexanol, 2,3,4-tris(phenylmethoxy)-, (1R,2S,3S,4R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanol, 2,3,4-tris(phenylmethoxy)-, (1R,2S,3S,4R)-(197896-26-7)
• EPA Substance Registry System: Cyclohexanol, 2,3,4-tris(phenylmethoxy)-, (1R,2S,3S,4R)-(197896-26-7)

Safety Data

• Hazardous Substances Data: 197896-26-7(Hazardous Substances Data)

Upstream product

• 197896-25-6 Benzoic acid (1R,2S,3S,4R)-2,3,4-tris-benzyloxy-cyclohexyl ester 
• 220564-16-9 (-)-(1R,2S,3S,4R)-2,3,4-tribenzyloxy-5-cyclohexene-1-ol 
• 197896-24-5 Benzoic acid (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-phenoxythiocarbonyloxy-cyclohexyl ester 
• 197896-23-4 Benzoic acid (1R,2R,3S,4R,6R)-2,3,4-tris-benzyloxy-6-hydroxy-cyclohexyl ester 
• 162792-19-0 (3aR,4R,5S,6R,7aR)-4,5,6-Tris-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxole 
• 162792-20-3 (1R,2R,3S,4S,5R)-3,4,5-Tris-benzyloxy-cyclohexane-1,2-diol 
• 800408-98-4 (1S,4S,5S,6S)-4,5,6-tris(benzyloxy)cyclohex-2-enol 
• 671199-46-5 (4R,5S,6R)-4,5,6-tris(benzyloxy)cyclohex-2-en-1-one 
• 498554-88-4 1D-4,5,6-tri-O-benzyl-3-deoxy-1-O-p-methoxybenzyl-myo-inositol 

Downstream Products

• 197896-27-8 Diisopropyl-phosphoramidous acid benzyl ester (1R,2R,3S,4R)-2,3,4-tris-benzyloxy-cyclohexyl ester 
• 197896-29-0 Hexadecanoic acid (R)-2-[benzyloxy-((1R,2R,3S,4R)-2,3,4-tris-benzyloxy-cyclohexyloxy)-phosphoryloxy]-1-hexadecanoyloxymethyl-ethyl ester 
• 197896-28-9 Hexadecanoic acid (R)-2-[benzyloxy-((1R,2R,3S,4R)-2,3,4-tris-benzyloxy-cyclohexyloxy)-phosphanyloxy]-1-hexadecanoyloxymethyl-ethyl ester 
• 701976-55-8 phosphoric acid 2-methoxy-3-octadecyloxy-propyl ester 2,3,4-trihydroxy-cyclohexyl ester 

Relevant articles and documents

AKT INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

Disclosed are inhibitors of the serine/threonine kinase Akt, pharmaceutical compositions comprising such inhibitors, and a method of preventing or treating a disease or condition in an animal by the use of such inhibitors. The Akt inhibitors have the form

Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt

The synthesis from l-quebrachitol of a series of 3-deoxygenated ether lipid-type phosphatidylinositol (PI) analogues is reported, that selectively block activation of Akt and downstream substrates without affecting activation of the upstream kinase, PDK-1